Table 2: Patient characteristics among various disease conditions.
|
|
No. (%) |
|
|
|
|
|
|
|
Characteristic |
PG |
All Derm |
Psoriasis |
Atopic Dermatitis |
Skin Cancer |
General WFBH |
P value |
|
Sample Size |
|
|
|
|
|
|
|
|
All |
255 |
1020 |
1020 |
1020 |
1020 |
1020 |
NA |
|
Female patients |
183 |
732 |
732 |
732 |
732 |
732 |
NA |
|
Male patients |
72 |
288 |
288 |
288 |
288 |
288 |
NA |
|
Age, mean (SD), y |
60.3 (15.3) |
60.3 (15.3) |
60.3 (15.3) |
60.3 (15.3) |
60.3 (15.3) |
60.3 (15.3) |
NA |
|
Race |
|
|
|
|
|
|
|
|
White |
188 (73.7) |
821 (80.5) |
887 (87.0) |
649 (63.6) |
821 (80.5) |
825 (80.9) |
NA |
|
Black |
60 (23.5) |
198 (19.4) |
117 (11.5) |
335 (32.8) |
198 (19.4) |
182 (17.8) |
NA |
|
Latin American or Hispanic |
1 (< 1) |
0 |
0 |
0 |
0 |
2 (< 1) |
NA |
|
Asian |
0 |
1 (< 1) |
6 (< 1) |
14 (1.4) |
1 (< 1) |
1 (<1) |
NA |
|
Alaskan native or American Indian |
2 (< 1) |
0 |
1 (< 1) |
4 (< 1) |
0 |
0 |
NA |
|
Other |
4 (1.6) |
0 |
9 (< 1) |
18 (1.8) |
0 |
10 (1.0) |
NA |
|
BMI |
32.3 (9.5) |
29.9 (7.6) |
30.8 (8.8) |
30.0 (7.7) |
29.9 (7.6) |
29.1 (7.4) |
< 0.001* |
|
Comorbidities |
|
|
|
|
|
|
|
|
Joint |
68 (26.7) |
NA |
NA |
NA |
NA |
NA |
NA |
|
GI |
99 (38.8) |
NA |
NA |
NA |
NA |
NA |
NA |
|
Hematologic |
16 (6.3) |
NA |
NA |
NA |
NA |
NA |
NA |
|
Collagen-vascular |
7 (2.7) |
NA |
NA |
NA |
NA |
NA |
NA |
|
Cancer |
25 (9.8) |
NA |
NA |
NA |
NA |
NA |
NA |
|
Other |
71 (27.8) |
NA |
NA |
NA |
NA |
NA |
NA |
|
None |
80 (31.4) |
NA |
NA |
NA |
NA |
NA |
NA |
|
Insurance Type |
N = 254 |
N = 1020 |
N = 1017 |
N = 1018 |
N = 1020 |
N = 1020 |
< 0.001** |
|
No insurance |
27 (10.6) |
32 (3.1) |
52 (5.1) |
50 (4.9) |
34 (3.3) |
45 (4.4) |
|
|
Medicaid |
36 (14.2) |
104 (10.2) |
96 (9.4) |
123 (12.1) |
104 (10.2) |
78 (7.7) |
|
|
Medicare |
119 (46.9) |
397 (38.9) |
446 (43.9) |
367 (36.0) |
397 (38.9) |
404 (39.6) |
|
|
Private |
72 (28.3) |
487 (47.8) |
423 (41.6) |
478 (47.0) |
485 (47.6) |
493 (48.3) |
|
|
SES Index |
|
|
|
|
|
|
< 0.001** |
|
Very Low SES |
83 (32.6) |
254 (24.9) |
161 (15.8) |
207 (20.3) |
252 (24.7) |
206 (20.2) |
|
|
Low SES |
33 (12.9) |
148 (14.5) |
175 (17.2) |
128 (12.6) |
147 (14.4) |
202 (19.8) |
|
|
Moderate SES |
31 (12.1) |
148 (14.5) |
146 (14.3) |
150 (14.7) |
150 (14.7) |
204 (20.0) |
|
|
High SES |
56 (22.0) |
252 (24.7) |
335 (32.8) |
343 (33.6) |
253 (24.8) |
204 (20.0) |
|
|
Very High SES |
52 (20.4) |
218 (21.4) |
203 (19.9) |
192 (18.8) |
218 (21.4) |
204 (20.0) |
|
|
Abbreviations: NA - not applicable. (*) T-test for significance, (**) Chi-Square test for significance. |
|||||||